Metabolic myopathies

Alan N. Baer

doi:10.1007/978-0-387-68566-3_19

Metabolic myopathies

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

The metabolic myopathies are a heterogeneous group of diseases characterized by impaired skeletal muscle energy production. Primary metabolic myopathies are associated with genetically determined defects in glycogen and lipid metabolism and in mitochondrial oxidative phosphorylation. These include the muscle glycogenoses and the lipid and mitochondrial myopathies. Other metabolic myopathies arise from endocrine or electrolyte abnormalities and therapy with specific drugs. A classification of the primary metabolic myopathies is presented in Table 19-1.

Original language	English (US)
Title of host publication	Primer on the Rheumatic Diseases
Subtitle of host publication	Thirteenth Edition
Publisher	Springer New York
Pages	381-388
Number of pages	8
ISBN (Print)	9780387356648
DOIs	https://doi.org/10.1007/978-0-387-68566-3_19
State	Published - Dec 1 2008
Externally published	Yes

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1007/978-0-387-68566-3_19

Cite this

@inbook{c1f961d15ec14721bee6d36c3acf70c8,

title = "Metabolic myopathies",

abstract = "The metabolic myopathies are a heterogeneous group of diseases characterized by impaired skeletal muscle energy production. Primary metabolic myopathies are associated with genetically determined defects in glycogen and lipid metabolism and in mitochondrial oxidative phosphorylation. These include the muscle glycogenoses and the lipid and mitochondrial myopathies. Other metabolic myopathies arise from endocrine or electrolyte abnormalities and therapy with specific drugs. A classification of the primary metabolic myopathies is presented in Table 19-1.",

author = "Baer, {Alan N.}",

year = "2008",

month = dec,

day = "1",

doi = "10.1007/978-0-387-68566-3_19",

language = "English (US)",

isbn = "9780387356648",

pages = "381--388",

booktitle = "Primer on the Rheumatic Diseases",

publisher = "Springer New York",

}

TY - CHAP

T1 - Metabolic myopathies

AU - Baer, Alan N.

PY - 2008/12/1

Y1 - 2008/12/1

N2 - The metabolic myopathies are a heterogeneous group of diseases characterized by impaired skeletal muscle energy production. Primary metabolic myopathies are associated with genetically determined defects in glycogen and lipid metabolism and in mitochondrial oxidative phosphorylation. These include the muscle glycogenoses and the lipid and mitochondrial myopathies. Other metabolic myopathies arise from endocrine or electrolyte abnormalities and therapy with specific drugs. A classification of the primary metabolic myopathies is presented in Table 19-1.

AB - The metabolic myopathies are a heterogeneous group of diseases characterized by impaired skeletal muscle energy production. Primary metabolic myopathies are associated with genetically determined defects in glycogen and lipid metabolism and in mitochondrial oxidative phosphorylation. These include the muscle glycogenoses and the lipid and mitochondrial myopathies. Other metabolic myopathies arise from endocrine or electrolyte abnormalities and therapy with specific drugs. A classification of the primary metabolic myopathies is presented in Table 19-1.

UR - http://www.scopus.com/inward/record.url?scp=84892276861&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892276861&partnerID=8YFLogxK

U2 - 10.1007/978-0-387-68566-3_19

DO - 10.1007/978-0-387-68566-3_19

M3 - Chapter

AN - SCOPUS:84892276861

SN - 9780387356648

SP - 381

EP - 388

BT - Primer on the Rheumatic Diseases

PB - Springer New York

ER -

Metabolic myopathies

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this